NASDAQ · Healthcare · Biotechnology
AgomAb Therapeutics N.V. American Depositary Shares
AGMB
AgomAb Therapeutics N. CEO Tim Knotnerus · Market cap $433.4M.
$8.80
-0.04 · -0.45%
52w hi $17.8252w lo $7.97
Off 52w high 50.6%
84
STRONG
Current InsiderScore
Corp · 90d
6
6 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
6
4 strong · 2 notable
Analyst consensus
—
Avg PT $35.00
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Oct 06 | David R Epstein | Buy | 5,000 | $8.70 | +$44K | 73 | |
| Oct 06 | Tim Jasper Knotnerus | Chief Executive Officer | Buy | 5,000 | $8.70 | +$44K | 79 |
| Oct 06 | Pierre Thadee Victor Kemula | Chief Financial Officer | Buy | 5,000 | $8.57 | +$43K | 79 |
| Oct 06 | Pierre Thadee Victor Kemula | Chief Financial Officer | Buy | 3,000 | $8.67 | +$26K | 79 |
| Oct 05 | David R Epstein | Buy | 5,000 | $8.57 | +$43K | 73 | |
| Oct 05 | Tim Jasper Knotnerus | Chief Executive Officer | Buy | 6,000 | $8.48 | +$51K | 84 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct